Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Capstone Holding Stock News

CAPSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$2.45

0.7947.59%

At close: -

$2.22

-0.23-9.39%

After Hours: May 16, 7:59 PM EDT

Capstone Holding (CAPS) Forecast

News

Earnings Capstone Holding (CAPS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Capstone Holding Stock News | NASDAQ:CAPS | Benzinga

Get the latest news on Capstone Holding stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Capstone Holding performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, May 16, 2025

Deal Dispatch: Starbucks Eyes China Sell-Off, Li-Cycle Powers Down, VCs Tackle 49ers Stake
Anthony Noto
Capstone Takes Big Swing On Acquisitions, Shares Soar
Akanksha Bakshi
Capstone Reaffirms $100M Revenue Target for 2...
Benzinga Newsdesk

Wednesday, April 09, 2025

EXCLUSIVE: Capstone Holding Tells Benzinga Co...
Benzinga Newsdesk
EXCLUSIVE: Capstone Eyes $100 Million Goal With Southeast Expansion, Targets 1,500 Acquisition Opportunities
Anusuya Lahiri

Tuesday, April 01, 2025

EXCLUSIVE: Capstone Clocks 8% Q4 Revenue Growth, Aims For $100 Million Revenue Run Rate By 2025
Anusuya Lahiri
EXCLUSIVE: Capstone Holding Tells Benzinga 'R...
Benzinga Newsdesk
EXCLUSIVE: Capstone Holding Tells Benzinga Co...
Benzinga Newsdesk

Tuesday, March 25, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights

Monday, March 24, 2025

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights

Monday, March 17, 2025

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights

Friday, January 20, 2012

Capstone Therapeutics Announces Operational Update; Moving to OTC to Save Cash
Benzinga

Wednesday, July 20, 2011

Biotech/Pharma Stocks Investor News Alert
Benzinga

Wednesday, July 06, 2011

Capstone Therapeutics Announces Pre-Clinical Results With AZX100 in Radiation and Bleomycin Models of Pulmonary Fibrosis; Pulmonary Anti-Fibrotic Effect Demonstrated
Benzinga

Wednesday, June 22, 2011

Citadel Securities Reiterates Neutral Rating On Savient Pharmaceuticals
Benzinga

Tuesday, May 31, 2011

Capstone Therapeutics Signs Alliance With BiolineRx to Develop Chrysalin (TP508) in Acute Myocardial Infarction
Benzinga

Monday, May 02, 2011

CEOWORLD TOP 5 higher priced Biotechnology stocks picks- BIIB, CBST, MYGN, REGN and ITMN
Benzinga

Tuesday, December 28, 2010

Jolt for Regeneron's Pipeline - Analyst Blog
Benzinga
Jolt for Regeneron's Pipeline - Analyst Blog
Benzinga

Thursday, September 09, 2010

Good News for Regeneron - Analyst Blog
Benzinga

Wednesday, May 05, 2010

Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals Inc., Sanofi-Aventis, AstraZeneca, Interactive Data Corp. and Thompson Reuters - Press Releases
Benzinga

Tuesday, May 04, 2010

Regenron Loss Narrower - Analyst Blog
Benzinga

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved